Continue to Site >>>

OTP

Tobacco

FDA Director to Speak at NATO Show

 By Thomas A. Briant on Apr. 08, 2015

Bonus update on pending state tobacco bills

Tobacco

A Call to Attend the 2015 NATO Show

 By Thomas A. Briant on Apr. 01, 2015

Show will be held April 22-23 in Las Vegas

General Merchandise/HBC

IRI, Kline Team Up on Consumer Healthcare Products Industry

Mar. 20, 2015

Alliance will offer intelligence, insights on Rx-to-OTC switches, innovation, more

Tobacco

NATO Responds to Study on Raising Legal Purchase Age

By Thomas A. Briant on Mar. 18, 2015

Problem will continue until there is a credible effort to change the willingness of adults to provide tobacco products to underage youth

CSP Magazine

OTP: Cut the Clutter

By Samantha Strong Murphey on Mar. 11, 2015

The tobacco category is undergoing upheaval as cigarette sales decline and other tobacco products move in to lap up the leftover market share. E-cigs, vapor, cigars, pipe tobacco, roll-your-own—they’re all demanding more attention, requiring a more purposeful, permanent place in the store landscape.

CSP Magazine

Industry Views: NATO Membership: The Right Decision

By Mary Szarmach on Mar. 11, 2015

The value of NATO membership is more than important; it is invaluable in the current legislative and regulatory environment.

CSP Magazine

Taxes: Up In Smoke

By Kelly Kurt on Mar. 11, 2015

Consumer backlash helps drive lawmakers away from tobacco taxes.

CSP Magazine

Vaping: The Smoke Lifts

By Lara Jackson and Mitch Morrison on Mar. 11, 2015

Are they a trend or mainstay? Questions remain for e-cigs and vaping.

CSP Magazine

Editor's Note: Embrace the New But Keep the Core

By Melissa Vonder Haar on Mar. 10, 2015

Convenience stores have established themselves as power players in the world of foodservice. It’s no longer your father’s (or grandfather’s) c-store. And perhaps nowhere is this shift more apparent than in the core categories of tobacco and beer.

CSP Magazine

Cover Story: Dire Deeming

By Melissa Vonder Haar on Mar. 10, 2015

Could the FDA’s proposed regulations represent a death sentence for innovation?

  • Page 102